84 related articles for article (PubMed ID: 20060467)
21. Permeation of quinine across sublingual mucosa, in vitro.
Ong CM; Heard CM
Int J Pharm; 2009 Jan; 366(1-2):58-64. PubMed ID: 18835345
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
24. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design.
Patel VM; Prajapati BG; Patel MM
AAPS PharmSciTech; 2007 Jun; 8(2):Article 45. PubMed ID: 17622120
[TBL] [Abstract][Full Text] [Related]
25. Overview and appraisal of the current concept and technologies for improvement of sublingual drug delivery.
Wang Z; Chow MS
Ther Deliv; 2014 Jul; 5(7):807-16. PubMed ID: 25287387
[TBL] [Abstract][Full Text] [Related]
26. Permeation studies on freshly excised rat gastric mucosa: influence of pH.
Leithner K; Grabovac V; Albrecht K; Hombach J; Klima G; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 May; 37(5):518-25. PubMed ID: 21126214
[TBL] [Abstract][Full Text] [Related]
27. Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem.
Xia B; Yang Z; Zhou H; Lukacova V; Zhu W; Milewski M; Kesisoglou F
AAPS J; 2015 May; 17(3):631-42. PubMed ID: 25716146
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
29. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.
Nakamura K; Nara E; Akiyama Y
J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets.
Shoukri RA; Ahmed IS; Shamma RN
Eur J Pharm Biopharm; 2009 Sep; 73(1):162-71. PubMed ID: 19406232
[TBL] [Abstract][Full Text] [Related]
31. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
32. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
Rawas-Qalaji MM; Simons FE; Simons KJ
Biopharm Drug Dispos; 2006 Dec; 27(9):427-35. PubMed ID: 17009337
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance.
Bredenberg S; Duberg M; Lennernäs B; Lennernäs H; Pettersson A; Westerberg M; Nyström C
Eur J Pharm Sci; 2003 Nov; 20(3):327-34. PubMed ID: 14592698
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
35. Sublingual administration of furosemide: new application of an old drug.
Haegeli L; Brunner-La Rocca HP; Wenk M; Pfisterer M; Drewe J; Krähenbühl S
Br J Clin Pharmacol; 2007 Dec; 64(6):804-9. PubMed ID: 17875188
[TBL] [Abstract][Full Text] [Related]
36. Enhanced ex vivo buccal transport of propranolol: evaluation of phospholipids as permeation enhancers.
Lee J; Choi YW
Arch Pharm Res; 2003 May; 26(5):421-5. PubMed ID: 12785740
[TBL] [Abstract][Full Text] [Related]
37. Rise of testosterone, nortestosterone, and 17beta-estradiol concentrations in peripheral blood plasma of pigs after sublingual application in vivo.
Claus R; Häussler S; Lacorn M
Food Chem Toxicol; 2007 Feb; 45(2):225-8. PubMed ID: 17010491
[TBL] [Abstract][Full Text] [Related]
38. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex.
Halder A; Maiti S; Sa B
Int J Pharm; 2005 Sep; 302(1-2):84-94. PubMed ID: 16102927
[TBL] [Abstract][Full Text] [Related]
39. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
40. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
